FDA cracks down on DMAA - but this is just the start, not the end, of the debate, predicts CRN
date:Apr 28, 2012
Research: This is the end of a long run for DMAA
James Neal-Kababick, director of Oregon-based Flora Research Laboratories, said the crackdown was the end of a long run for DMAAand came as no surprise given that credible research has failed to indicate any detectable DMAA in geranium oil even using the power of a research grade High Resolution Gas Chromatography-Mass Spectroscopy instrument.
DMAA is methylhexaneamine, a drug developed by Lily in 1944 and was patented again in 1971 as Forthane, a

05/02 11:31